Pathogenesis of type 2 Epithelial to Mesenchymal Transition (EMT) in renal and hepatic fibrosis

43Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

Abstract

Epithelial to mesenchymal transition (EMT), particularly, type 2 EMT, is important in progressive renal and hepatic fibrosis. In this process, incompletely regenerated renal epithelia lose their epithelial characteristics and gain migratory mesenchymal qualities as myofibroblasts. In hepatic fibrosis (importantly, cirrhosis), the process also occurs in injured hepatocytes and hepatic progenitor cells (HPCs), as well as ductular reaction-related bile epithelia. Interestingly, the ductular reaction contributes partly to hepatocarcinogenesis of HPCs, and further, regenerating cholangiocytes after injury may be derived from hepatic stellate cells via mesenchymal to epithelia transition, a reverse phenomenon of type 2 EMT. Possible pathogenesis of type 2 EMT and its differences between renal and hepatic fibrosis are reviewed based on our experimental data.

Cite

CITATION STYLE

APA

Tennakoon, A. H., Izawa, T., Kuwamura, M., & Yamate, J. (2015, December 30). Pathogenesis of type 2 Epithelial to Mesenchymal Transition (EMT) in renal and hepatic fibrosis. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm5010004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free